Bank of America Boosts Hims & Hers Health (NYSE:HIMS) Price Target to $23.00

Hims & Hers Health (NYSE:HIMS – Free Report) had its price target upped by Bank of America from $20.00 to $23.00 in a report published on Monday, Benzinga reports. The brokerage currently has a buy rating on the stock. Several other brokerages have also issued reports on HIMS. Imperial Capital lowered shares of Hims & […]

Leave a Reply

Your email address will not be published.

Previous post BMO Capital Markets Raises Sunnova Energy International (NYSE:NOVA) Price Target to $10.00
Next post Rollins, Inc. (NYSE:ROL) Receives Consensus Rating of “Moderate Buy” from Brokerages